Testosterone and cardiometabolic risk in the general population - the impact of measurement method on risk associations: A comparative study between immunoassay and mass spectrometry

European Journal of Endocrinology

Volumn 169, Issue 4, 2013, Pages 463-470

  Haring, Robin ^a   Baumeister, Sebastian E ^a   Nauck, Matthias ^a   Volzke, Henry ^a   Keevil, Brian G ^b   Brabant, Georg ^b   Wallaschofski, Henri ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TESTOSTERONE;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOMETABOLIC RISK; CHEMILUMINESCENCE ANALYZER; CHEMILUMINESCENCE IMMUNOASSAY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FIBRINOGEN BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; INTERMETHOD COMPARISON; LIPID METABOLISM; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY; MALE; MASS SPECTROMETER; MEASUREMENT ACCURACY; MEASUREMENT ERROR; OBESITY; PRIORITY JOURNAL; RISK FACTOR; TANDEM MASS SPECTROMETRY; TESTOSTERONE BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHROMATOGRAPHY, LIQUID; CROSS-SECTIONAL STUDIES; GERMANY; HUMANS; IMMUNOASSAY; MALE; MASS SPECTROMETRY; METABOLIC DISEASES; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RISK FACTORS; TESTOSTERONE; YOUNG ADULT;

EID: 84884858491     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-13-0222     Document Type: Article

References (37)

1. Ruige JB, Mahmoud AM, De Bacquer D & Kaufman JM. Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis. Heart 2010 97 870-875. (doi:10.1136/hrt.2010.210757)
2. Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT & Wittert GA. Endogenous testosterone and mortality in men: a systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism 2011 96 3007-3019. (doi:10.1210/jc. 2011-1137)
3. Brand JS, van der Tweel I, Grobbee DE, Emmelot-Vonk MH & van der Schouw YT. Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies. International Journal of Epidemiology 2011 40 189-207. (doi:10.1093/ije/dyq158)
4. Ding EL, Song Y, Malik VS & Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. Journal of the American Medical Association 2006 295 1288-1299. (doi:10.1001/jama.295.11.1288)
5. Haring R, John U, Volzke H, Nauck M, Dorr M, Felix SB & Wallaschofski H. Low testosterone concentrations in men contribute to the gender gap in cardiovascular morbidity and mortality. Gender Medicine 2012 9 557-568. (doi:10.1016/j.genm.2012.10.007)
6. Wheeler MJ & Barnes SC. Measurement of testosterone in the diagnosis of hypogonadism in the ageing male. Clinical Endocrinology 2008 69 515-525. (doi:10.1111/j.1365-2265.2008. 03325.x)
7. Haring R, Spielhagen C & Nauck M. Challenges in the measurement of serum testosterone concentrations as a biomarker of men's health. Journal of Laboratory and Clinical Medicine 2011 35 1-5. (doi:10.1515/JLM.2011.001-engl)
8. Rosner W, Auchus RJ, Azziz R, Sluss PM & Raff H. Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. Journal of Clinical Endocrinology and Metabolism 2007 92 405-413. (doi:10.1210/jc.2006-1864)
9. Bhasin S, Zhang A, Coviello A, Jasuja R, Ulloor J, Singh R, Vesper H & Vasan RS. The impact of assay quality and reference ranges on clinical decision making in the diagnosis of androgen disorders. Steroids 2008 73 1311-1317. (doi:10.1016/j.steroids.2008.07. 003)
10. Vesper HW, Bhasin S, Wang C, Tai SS, Dodge LA, Singh RJ, Nelson J, Ohorodnik S, Clarke NJ, Salameh WA et al. Interlaboratory comparison study of serum total testosterone [corrected] measurements performed by mass spectrometry methods. Steroids 2009 74 498-503. (doi:10.1016/j.steroids. 2009.01.004)
11. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS & Montori VM. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2010 95 2536-2559. (doi:10.1210/jc.2009-2354)
12. Huhtaniemi IT, Tajar A, Lee DM, O'Neill TW, Finn JD, Bartfai G, Boonen S, Casanueva FF, Giwercman A, Han TS et al. Comparison of serum testosterone and estradiol measurements in 3174 European men using platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men. European Journal of Endocrinology 2012 166 983-991. (doi:10.1530/EJE-11-1051)
13. Stanczyk FZ, Lee JS & Santen RJ. Standardization of steroid hormone assays: why, how, and when? Cancer Epidemiology, Biomarkers & Prevention 2007 16 1713-1719. (doi:10.1158/1055-9965.EPI-06-0765) (Pubitemid 47450498)
14. Dorgan JF, Fears TR, McMahon RP, Aronson Friedman L, Patterson BH & Greenhut SF. Measurement of steroid sex hormones in serum: a comparison of radioimmunoassay and mass spectrometry. Steroids 2002 67 151-158. (doi:10.1016/S0039-128X(01)00147-7) (Pubitemid 34150134)
15. Hsing AW, Stanczyk FZ, Belanger A, Schroeder P, Chang L, Falk RT & Fears TR. Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry. Cancer Epidemiology, Biomarkers & Prevention 2007 16 1004-1008. (doi:10.1158/1055-9965.EPI-06-0792) (Pubitemid 46910104)
16. Volzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, Aumann N, Lau K, Piontek M, Born G et al. Cohort profile: the study of health in Pomerania. International Journal of Epidemiology 2011 40 294-307. (doi:10.1093/ije/dyp394)
17. Friedrich N, Volzke H, Rosskopf D, Steveling A, Krebs A, Nauck M & Wallaschofski H. Reference ranges for serum dehydroepiandrosterone sulfate and testosterone in adult men. Journal of Andrology 2008 29 610-617. (doi:10.2164/jandrol.108. 005561)
18. Haring R, Hannemann A, John U, Radke D, Nauck M, Wallaschofski H, Owen L, Adaway J, Keevil BG & Brabant G. Age-specific reference ranges for serum testosterone and androstenedione concentrations in women measured by liquid chromatography-tandem mass spectrometry. Journal of Clinical Endocrinology and Metabolism 2012 97 408-415. (doi:10.1210/jc.2011-2134)
19. Gallagher LM, Owen LJ & Keevil BG. Simultaneous determination of androstenedione and testosterone in human serum by liquid chromatography-tandem mass spectrometry. Annals of Clinical Biochemistry 2007 44 48-56. (doi:10.1258/00045630777 9595922) (Pubitemid 46168801)
20. Thienpont LM, Van Uytfanghe K, Blincko S, Ramsay CS, Xie H, Doss RC, Keevil BG, Owen LJ, Rockwood AL, Kushnir MM et al. State-of-the-art of serum testosterone measurement by isotope dilution-liquid chromatography-tandem mass spectrometry. Clinical Chemistry 2008 54 1290-1297. (doi:10.1373/clinchem. 2008.105841)
21. Cornbleet PJ & Gochman N. Incorrect least-squares regression coefficients in method-comparison analysis. Clinical Chemistry 1979 25 432-438. (Pubitemid 9142871)
22. Wooldridge J. Econometric Analysis of Cross Section and Panel Data. MIT Press, 2010.
23. Buonaccorsi JP. Measurement Error: Models, Methods, and Applications. Chapman and Hall/CRC, 2010.
24. Hutcheon JA, Chiolero A & Hanley JA. Random measurement error and regression dilution bias. BMJ 2010 340 c2289. (doi:10.1136/bmj.c2289)
25. Knuiman MW, Divitini ML, Buzas JS & Fitzgerald PE. Adjustment for regression dilution in epidemiological regression analyses. Annals of Epidemiology 1998 8 56-63. (doi:10.1016/S1047-2797(97)00107-5) (Pubitemid 28058954)
26. Taieb J, Mathian B, Millot F, Patricot MC, Mathieu E, Queyrel N, Lacroix I, Somma-Delpero C & Boudou P. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clinical Chemistry 2003 49 1381-1395. (doi:10.1373/49.8. 1381) (Pubitemid 36900626)
27. Wang C, Catlin DH, Demers LM, Starcevic B & Swerdloff RS. Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. Journal of Clinical Endocrinology and Metabolism 2004 89 534-543. (doi:10.1210/jc.2003- 031287) (Pubitemid 38269854)
28. Haring R, Baumeister SE, Volzke H, Dorr M, Kocher T, Nauck M & Wallaschofski H. Prospective inverse associations of sex hormone concentrations in men with biomarkers of inflammation and oxidative stress. Journal of Andrology 2012 33 944-950. (doi:10. 2164/jandrol.111.015065)
29. Haring R, Baumeister SE, Volzke H, Dorr M, Felix SB, Kroemer HK, Nauck M & Wallaschofski H. Prospective association of low total testosterone concentrations with an adverse lipid profile and increased incident dyslipidemia. European Journal of Cardiovascular Prevention and Rehabilitation 2011 18 86-96. (doi:10.1097/HJR. 0b013e32833c1a8d)
30. Haring R, Volzke H, Felix SB, Schipf S, Dorr M, Rosskopf D, Nauck M, Schofl C & Wallaschofski H. Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania. Diabetes 2009 58 2027-2031. (doi:10.2337/db09-0031)
31. Schipf S, Haring R, Friedrich N, Nauck M, Lau K, Alte D, Stang A, Volzke H & Wallaschofski H. Low total testosterone is associated with increased risk of incident type 2 diabetes mellitus in men: results from the Study of Health in Pomerania (SHIP). Aging Male 2011 14 168-175. (doi:10.3109/13685538. 2010.524955)
32. Bhasin S, Pencina M, Jasuja GK, Travison TG, Coviello A, Orwoll E, Wang PY, Nielson C, Wu F, Tajar A et al. Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. Journal of Clinical Endocrinology and Metabolism 2011 96 2430-2439. (doi:10.1210/jc.2010-3012)
33. Haring R, Volzke H, Steveling A, Krebs A, Felix SB, Schofl C, Dorr M, Nauck M & Wallaschofski H. Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79. European Heart Journal 2010 31 1494-1501. (doi:10.1093/eurheartj/ehq009)
34. Jankowska EA, Biel B, Majda J, Szklarska A, Lopuszanska M, Medras M, Anker SD, BanasiakW, Poole-Wilson PA & Ponikowski P. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival. Circulation 2006 114 1829-1837. (doi:10.1161/CIRCULATIONAHA.106.649426) (Pubitemid 44673358)
35. Haring R, Baumeister SE, Volzke H, Kohlmann T, Marschall P, Flessa S, Nauck M & Wallaschofski H. Prospective association of low serum total testosterone levels with health care utilization and costs in a population-based cohort of men. International Journal of Andrology 2010 33 800-809. (doi:10.1111/j.1365-2605.2009. 01029.x)
36. Stanczyk FZ & Clarke NJ. Advantages and challenges of mass spectrometry assays for steroid hormones. Journal of Steroid Biochemistry and Molecular Biology 2010 121 491-495. (doi:10. 1016/j.jsbmb.2010.05.001)
37. Vesper HW & Botelho JC. Standardization of testosterone measurements in humans. Journal of Steroid Biochemistry and Molecular Biology 2010 121 513-519. (doi:10.1016/j.jsbmb. 2010.03.032)